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Introduction
Leukemia is a hematological and genetically acquired pathology 
of  the hematopoietic system, originating in the bone marrow, the 
site of  production of  blood cells. Leukemia appears with a fre-
quency of  17.0% in the first year of  life, with a peak incidence 
of  2 to 3 years with 80 cases per million, being three times more 
prevalent in the Caucasian race [6].
With regard to childhood cancer, leukemia accounts for 30.0% of  
childhood neoplasms, is one of  the most common neoplasias and 
most affects individuals from 0 to 15 years old, and is the main 
cause of  childhood cancer deaths in Brazil [3].
In Brazil, the expectation of  new cases is around 1 in 300 chil-
dren and adolescents. The most common leukemia in children 
are lymphoblastic leukemias, that is, acute lymphoids (ALL), cor-
responding to 80.0% of  the cases. Lymphoblastic leukemia origi-
nates in lymphoid cells (lymphocytes), presenting as main signs 
and symptoms fever in 50.0% of  cases, bone and joint pain, pal-
lor, fatigue, weight loss, subcutaneous nodules, headache, vomit-
ing, cutaneous bleeding (epistaxis, petechiae, equizemas) and ad-
enomegaly in 85.0% of  patients [4].
The diagnosis is made through several tests, such as the hemo-
gram, analysis of  hemoglobins, which in 80.0% of  cases is usu-
ally below 10 g/dl. Approximately 75.0% of  leukemic patients 
develop platelet thrombocytopenia. The exam that defines the 
diagnosis of  leukemia is the myelogram [3].
The standard treatment consists of  use of  antineoplastic-based 
chemotherapy or radiotherapy these therapies advocated may 
cause various side effects mainly due to immunosuppressive con-
ditions [4].
The main oral alterations that affect patients taking antineoplastic 
drugs are craniofacial alterations, mucositis, candidiasis, xerosto-
mia, gingival bleeding, trismus, hemorrhages, dental caries, other 
viral infections, dysgeusia and osteoradionecrosis, which can di-
rectly affect health, daily activities and in the quality of  life of  
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Abstract
Leukemia is a haematological neoplasm that among 300 children and adolescents in Brazil. Its standard treatment consists 
of  the use of  antineoplastic based on chemotherapy or radiotherapy, these recommended therapies can provoke several side 
effects among them buccal alterations mainly due to the immunosupression picture. In view of  the exposed this study has 
the objective to describe the main updates of  the dental care to the child carrier of  leukemia by reviewing the literature. Im-
munosuppression and the very fragility and stage of  development of  children with leukemia lead to greater vulnerability to all 
types of  opportunistic infections and pathologies resulting from antineoplastic therapy. Currently, modern oncology requires 
the presence of  the dentist in all phases of  treatment and even before diagnosis in a sine qua non condition for management, 
maintenance of  oral health and quality of  life of  the leukemic patient. The dentist besides being part of  the cancer team is 
required both in the in-hospital environment and in daily clinical practice. Currently there is a wide range of  resources and 
medicines to promote a satisfactory handling and quality of  life for these patients.
Keywords: Child; Leukemia; Oral Health; Dental Care.
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patients, besides being a focus for other infections [4].
When 24 children with leukemia were searched, it was found 
that only 28.6% of  these patients had favorable oral health, the 
remaining 71.4% presented unfavorable oral health, with oral 
complications of  chemotherapy such as the higher prevalence of  
mucositis, xerostomia, dysphagia , dysgeusia, candidiasis, gingival 
bleeding, cold sores and odontoalgia evidencing the need for and 
dental intervention [11].
Oral manifestations in pediatric patients may be expressed prior 
to the confirmed diagnosis of  leukemia and accentuated during 
anti-neoplastic treatment, may be treated by the dentist with a 
stomatology specialization or even the generalist dentist who has 
a relevant role in the treatment with the medical team in the pre-
vention, diagnosis, control and treatment of  these changes in the 
oral cavity in modern oncology [4].
In view of  the above, this study aimed to describe the main up-
dates of  the dental care of  children with leukemia through litera-
ture review.
Methods
Experimental and clinical studies were included (case reports, ret-
rospective, prospective and randomized trials) with qualitative and 
/or quantitative analysis. Initially, the key words were determined 
by searching the DeCS tool (Descriptors in Health Sciences, BI-
REME base) and later verified and validated by MeSh system 
(Medical Subject Headings, the US National Library of  Medicine) 
in order to achieve consistent search.
Mesh Terms
The words were included child, leukemia, oral health, dental care. 
For further specification, the leukemia, oral health description for 
refinement was added during searches. The literature search was 
conducted through online databases: Pubmed, Periodicos.com 
and Google Scholar. It was stipulated deadline, and the related 
search covering all available literature on virtual libraries.
Series of  Articles And Eligibility
A total of  42 articles were found involving temporomandibular 
dysfunction. Initially, it was held the exclusion existing title and 
duplications in accordance with the interest described this work. 
After this process, the summaries were evaluated and a new exclu-
sion was held. A total of  25 articles were evaluated in full, and 19 
were included and discussed in this study.
Literature Review
Craniofacial Changes
Changes in craniofacial development can occur in two ways: di-
rect and indirect. Direct changes affect the sites on growth or 
around the soft tissues. Indirect changes occur in the form of  
hormonal deficiency and puberty disorders caused by cranial ir-
radiation to the hypothalamic-pituitary axis. These changes lead 
to anomalies in the structure of  the dental roots, incomplete cal-
cification, premature closure of  apices, delay or acceleration in 
dental development and lesions of  caries, it also results in cases of  
trismus, abnormal occlusal relations and facial deformities.
Children exposed to chemotherapy or radiation during the devel-
opmental stages of  dental germs during the formative years (be-
fore 9 years of  age) may present hypomineralization or hypoma-
tology of  enamel or short, thin and tapered root formation, with 
a defective enamel and dentin discolored in deformed crowns. 
Direct radiation to the head and neck can lead to incomplete de-
velopment of  the jaws, smaller teeth, stuck teeth, overlapping soft 
tissue atrophy, malformation of  hard tooth tissues such as enamel 
and incomplete calcification of  teeth. The younger the child, the 
greater the risk of  craniofacial abnormalities [12].
The study of  Lauritano, Petruzzi [10] with 50 children who sur-
vived leukemia, aged 8 to 15 years evaluated the possible effects 
of  anti-leukaemic therapy on dental development are at greater 
risk of  developing dental caries and present greater severity of  
dental anomalies, including V-shaped roots, dental agenesis, mi-
crodontia, enamel dysplasias. Concluding that pediatric patients 
with leukemia require special attention in dental care.
Radiotherapy promotes dental changes in 90 to 100% of  cases, in 
the case of  doses ranging from 20-40 Gy, it may lead to the for-
mation of  crown and short root teeth, hypocalcification, abnor-
mal root curvature, amelogenesis and imperfect dentinogenesis.
According to Javed et al., [7] children with leukemia are more sus-
ceptible and more prevalent to changes in odontogenesis (enamel 
hypoplasia, halting in the development of  the dental organ, ano-
dontia, microdontiae) and rhizogenesis (short roots and sharp 
roots) besides agenesis.
Muscle Trismus
Muscle trismus is the limitation of  mouth opening due to edema, 
cellular destruction and fibrosis of  the muscle tissue induced by 
radiation, making correct oral hygiene difficult. The degree of  re-
striction depends on factors such as radiation dose, tumor loca-
tion and radiation distribution [5].
The recommended treatment includes exercises to stimulate the 
opening and closing of  the mouth, with concomitant application 
of  moist heat before and after exercise and administration of  an-
ti-inflammatory medication and muscle relaxants [5].
Dental Carie
It is common for the presence of  caries in children with leukemia 
due to factors such as increased demineralization and acidophilic 
organisms (Streptococcus mutans), change in buccal microflora, 
poor oral hygiene, reduced salivary flow and loss of  taste associ-
ated with a more cariogenic diet ( more soft and sweet) results in 
rapid tooth destruction [5].
The dentist should encourage and strengthen the use of  topical 
fluorides, promote dietary restrictions and require regular visits to 
the dentist every 03 months. The use of  antimicrobials may help 
to eliminate infection [5].
The use of  fluoride in the form of  mouthwash and toothpaste 
provides additional protection against tooth decay. The den-
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tist can apply concentrated fluorides and various remineralising 
agents in the form of  topical toothpaste of  phosphopeptides of  
amorphous calcium casein (CPP-ACP) directly into the teeth for 
5-10 minutes periodically to prevent and reverse the risk of  dental 
caries , increase remineralization [12, 17].
Candidíasis
This fungal infection caused by Candida albicans is one of  the most 
common opportunistic infections in pediatric leukemic patients. 
It occurs in periods of  immunosuppression and neutropenia, due 
to factors such as the use of  broad-spectrum antibiotics and an-
tineoplastic agents, inadequate oral hygiene, poor nutrition and 
physical condition weakened.
It can be presented in the following clinical forms: Pseudomembra-
nous candidiasis presenting white plaques with a classic appearance 
of  mucosal adhering to the mucosa that are removable by scrap-
ing, erythematous candidiasis characterized by the presence of  
red plaques and loss of  filiform papillae and chronic candidiasis 
with white plaques non-removable to the scraping where the le-
sions show pinpoint hemorrhagic areas. The dentist conducts the 
treatment of  candidiasis with the use of  antifungal agents derived 
from polyene agents, imidazole and triazines including clotrima-
zole and ketoconazole [12].
One of  the most commonly used topical medication is nystatin 
and its action depends directly on the time of  contact with the 
tissues. Or it may be used the systemic drug like fluconazole and 
itraconazole has also been shown to be effective in antifungal 
therapy [5].
Javed et al., [7] also recommends the use of  chlorhexidine gluco-
nate (0.12%) and essential oils because of  their bactericidal and 
fungicidal properties. Chlorhexidine gluconate (0.12%) forms a 
whitish membrane (by coagulation of  serum and salivary pro-
teins) in the inflamed mucosa, thus reducing the severity of  in-
flammation of  the oral mucosa.
Other Viral Infections
Children with leukemia may also have other viral infections such 
as herpes simplex, varicella zoster, cytomegalovirus, adenovirus 
and Epstein bar virus. Herpes simplex manifests as multiple ulcers 
in the corners of  the mouth, lips, palate and gingiva. An erythema 
can also be seen around ulcerative lesions. Antiviral drugs such as 
acyclovir and valaciclovir are used for their treatment. In strains 
resistant to these drugs, foscarnet is the drug of  choice [12].
Bleeding
Depending on the severity of  thrombocytopenia, hemorrhages 
occur due to inflammation of  the gingiva, ecchymosis, hemato-
ma and the presence of  petechiae. Factors such as oral hygiene, 
trauma associated with oral function, sharp tooth of  the denture, 
also contribute to bleeding. The gingiva, buccal mucosa, tongue, 
floor of  the mouth and soft palate are the most common sites of  
hemorrhages and petechiae. Spontaneous mucous petechiae and 
gingival bleeding may occur when the platelet level falls below 
20,000 cells per mm3 [12].
The dentist can prevent and reduce the risk of  bleeding more effi-
ciently by promoting the use of  regular soft toothbrush or electric 
toothbrush at least twice a day, guiding the intake of  soft or semi-
solid foods. In severe cases there is a need for platelet transfusion 
to control bleeding [12].
Gingival Bleeding
Due to the thrombocytopenia, leukemic patients may present 
spontaneous gingival bleeding or traumatic brushing most com-
monly associated with chemotherapy. The degree of  thrombocy-
topenia and immunosuppression increases the severity of  bleed-
ing. In these cases, regular oral hygiene is recommended, because 
when oral hygiene is inadequate or absent, gingival bleeding is 
exacerbated, making the severity of  the condition possible [5]. 
You can also gently massage the gums with your wet finger af-
ter brushing twice a day to reduce bleeding episodes. Sometimes 
topical hemostatic and antiseptic substances can be used as the 
povidine and iodine solution to minimize gingival bleeding [12].
Mucositis
Mucositis is an ulceration that presents in the form of  erythema 
and causes intense pain, interfering with food intake. It occurs 5-7 
days after therapy, especially if  drugs such as cyclophosphamide, 
doxorubicin, paclitaxel, 5-fluorouracil (5- FU) and methotrexate. 
They may be associated with mucositis, xerostomia and low neu-
trophil counts. The literature describes the occurrence in 50 to 
54% in children undergoing cancer therapy [5].
Chemotherapy induces these lesions primarily on non-keratinized 
surfaces. On the other hand, radiotherapy causes focal lesions in-
side the mucosa where the direct radiation occurred. The main 
signs and symptoms of  mucositis are changes in mucosal texture 
and staining, epithelial atrophy, mild to severe pain, cell desqua-
mation, resulting in symptomatic ulcers, difficulty in speech and 
feeding depending on the degree of  tissue loss and aggression of  
pathogens [5]. 
According to Goursand et al., [5] mucositis may present in 4 dis-
tinct phases: Inflammatory or vascular phase: is the initial phase, 
which occurs 24 to 36 hours after chemotherapy or radiotherapy. 
It has, as characteristics, increased vascularization of  epithelial 
cells and tissues due to the presence of  cytokines such as inter-
leukin 1 and tumor necrosis factor; epithelial phase: occurs 4 to 
5 days later, leading to a reduction of  cell turnover and causing 
tissue damage, atrophy and ulceration; ulcerative phase: occurs 
after 1 week of  chemotherapy or radiation therapy. Endotoxins 
progress to tissue damage and opportunistic bacteria, viruses and 
fungi can proliferate. Healing phase: begins 2 to 3 weeks, when 
the cells of  the mucosa and leukocytes begin and renew. Healing 
is complete if  there is no malnutrition and associated opportun-
istic infections [5].
Mucositis treatment is varied, palliative and includes mouthwash-
es, mouthwashes with 0.9% NaCl saline, 12.0% chlorhexidine, 
sodium bicarbonate, water, and dilute hydrogen peroxide that 
can provide symptomatic relief  as they create an environment 
alkaline, interfering with bacterial colonization, but if  there is a 
complaint of  pain and burning, normal saline is recommended 
[12, 17].
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There is also the option of  using epithelial protective agents 
(aluminum hydroxide, magnesium hydroxide), topical anesthet-
ics (lidocaine), topical analgesic (benzidamine) and non-steroidal 
anti-inflammatory drugs and the combination of  antifungal and 
systemic antibiotics (polymyxin E, tobramycin, amphotericin B 
and fluconazole) but the results are only palliative [2, 5, 17].
Some studies suggest low-power infrared laser applications to 
promote epithelial repair, analgesia and eliminate pain on the first 
application. Laser energy acts on the nerve endings of  the ulcer 
and causes the release of  P-endorphin, promoting biostimulation 
of  the tissue and facilitating a faster cure of  ulceration [5, 12].
However, low-power infrared laser should be recommended on a 
daily basis until there is remission of  symptoms. Alternatively, the 
applications can be carried out in a punctual way by scanning the 
areas with the presence of  lesions [12].
In other countries it is recommended to treat oral cryotherapy (ice 
chip suction), which induces biological response modifiers, avoid-
ing oral mucositis [12, 17].
Mucosal coating agents with bioadhesive agents such as hydroxy-
propyl cellulose, Amifostine, Topical Vitamins C, B, A and, Topi-
cal Betacarotene, Prostaglandin E (PGE2), Glutamine and Gran-
ulocyte Colony Stimulating Factor (GCSF) may also be useful as 
temporary physical barrier on mucosal ulcerations, thus providing 
relief  of  pain and improved healing [2, 12].
Other authors recommend that once the mucositis has developed, 
the dentist should perform oral assessments twice a day in the 
case of  hospitalized patients and frequent oral care (at least every 
4 hours and at bedtime) and may increase the frequency as the 
severity of  mucositis increases and should be oriented to meticu-
lous oral hygiene and symptom assessments [2, 12].
In severe cases, it is also recommended to perform atraumatic 
debridement of  necrotic tissue and to clean hard soft oral tissues 
with a gauze wound around a finger or with a disposable sponge 
moistened in a diluted solution of  sodium bicarbonate and water. 
Patients should be encouraged to use warm water with added bi-
carbonate of  sodium to rinse the mouth several times daily in case 
of  ulcerations and painful oral tissues [12].
According to Mathur, Dhillon, Kalra [12] complete resolution of  
mucositis occurs 7 to 14 days after initiation and discontinuation 
of  therapy and sometimes, radiation-induced mucositis can re-
main from weeks to months and regress slowly.
Xerostomia
Xerostomia is a sensation of  dryness of  the buccal cavity due to 
dysfunction of  the salivary glands, with qualitative and quantita-
tive alterations in the salivary flow. Saliva becomes more viscous 
with reduced salivary amylase, IgA, buffer capacity, less lubrica-
tion and protection capacity and with a high amount of  organic 
material and changes in coloration, from transparent to yellowish 
by induction of  fibrosis by radiotherapy, fat degeneration and aci-
nar, besides necrosis of  the salivary glands [5, 18].
Xerostomia may occur transiently during chemotherapy (being 
reversed within 48 hours) or in a severe, progressive or perma-
nent form in cases of  radiotherapy (reversion may occur 4 to 12 
months after therapy) [5].
Saliva shows acidic pH, and there is a change in bacterial flora 
from gram-positive to gram-negative in addition to inducing loss 
of  taste, appetite, lubrication, changes in the stages of  swallowing 
and digestion and causing some disorders such as nausea, vom-
iting and symptomatology leading patients to cariogenic eating 
habits [12].
In addition to compromising maintenance of  the barrier against 
external injuries and tooth integrity by the process of  mineraliza-
tion and demineralization [5, 18]. The treatment in most cases is 
unsatisfactory and consists of  reducing the discomfort caused by 
dryness of  the mouth with water intake, stimulation of  saliva re-
maining, use of  artificial saliva based on carboxymethyl cellulose 
or salivary substitutes and sugar-free chewing gum. Pilocarpine, 
a parasympathetic agonist and an efficient promoter of  salivary 
secretion, may be indicated [5, 12, 17].
The child should rinse with cold sterile water or normal saline as 
often as possible to keep the buccal tissues clean and wet, ensur-
ing the removal of  saliva and thick debris and reducing the risk of  
opportunistic infections [12].
Dysgeusia
It is the alteration of  the palate is a result of  the direct effect 
of  radiation on taste corpuscles and saliva changes, reducing by 
50.0% the perception of  bitters and acids. Chemotherapy drugs 
also cause bad taste, termed the venous taste phenomenon result-
ing from the diffusion of  the drug into the oral cavity [5, 12]. It 
is a transient change because the affected buttons usually regen-
erate, recovery of  the partial or total palate occurs between two 
and twelve months after radiotherapy, and can be corrected with 
a zinc supplementation at a dosage of  220 mg twice daily [5, 12].
Osteoradionecrosis
Osteoradionecrosis damages the endothelial coatings of  bone 
vessels resulting in hypocellularity, hypovascularisation, vasculitis 
followed by obliterated endarteritis, bone ischemia, fistula, and 
sometimes pathologic fracture of  the bone leading to a radiation-
induced wound healing defect and a sequence specific pathology 
[5, 12].
The mucosa becomes thinner with the formation of  telangectasia 
in the irradiated area making it more susceptible to mechanical 
lesions. There is a decrease in collagen formation, blood flow due 
to vessel changes and wound healing, thus reducing nutrients and 
defense cells. It most commonly affects the mandible because of  
its relatively low vascularity and presence of  teeth [12].
The ORN can be accompanied by severe pain, trismus, bone ex-
posure and pathological fracture. Subsequent trauma to the ir-
radiated area can cause a wound that does not heal. Breathing 
procedures such as exodontia or periodontal surgeries are con-
traindicated, and may be initial factors of  tissue decomposition 
and ORN [5].
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ORN can be minimized by the administration of  hyperbaric oxy-
gen, which improves tissue oxygenation, increases collagen syn-
thesis and stimulates angiogenesis. It is recommended that all chil-
dren be referred for oral examination one month prior to the start 
of  chemotherapy or radiotherapy and treatment of  pre-existing 
or associated oral diseases, pre-assessment and appropriate dental 
care are critical [12].
Emergency Dental Care during Leukemic Treatment
The oncologist and the hematologist should consult the dentist in 
case of  a dental emergency. In high-risk patients (active leukemia 
or bone marrow suppression phase), dental intervention is limited 
to emergency care, but oral hygiene should be maintained with the 
use of  mild mouthwashes and antiseptic and antimicrobial solu-
tions, ulcers and minimize complications due to infection [19].
In the case of  evidence of  oral infection, the high-risk patient 
should receive a broad-spectrum antibiotic intravenously [9]. The 
neutrophil count may fall dramatically after 7 to 10 days after in-
duction therapy leading to an increased risk of  infection during 
that period. It is recommended to perform smaller dental proce-
dures with a platelet count of  40,000/mm3 -50,000/mm3, where-
as for major surgeries, it is desirable that the platelet count is at 
least 100,000/mm3 [12, 17].
Platelet transfusion may be advised in case of  an emergency. Only 
if  the absolute neutrophil count exceeds 1000 per cubic millim-
eter, and the platelet count is appreciable, any dental treatment is 
performed [12, 17].
Oral Management after Completion of  Leukemia Treatment
Children with leukemia during the remission phase may be treated 
as normal patients, although blood tests should be considered if  
invasive treatment is required and periodic follow-up should be 
scheduled to monitor oral health at intervals of  3 to 6 months [8]. 
Patients who have been cured of  leukemia are considered low 
risk and can be treated with standard dental treatment regimens. 
Upon completion of  oncologic therapy and only after two years 
free from the disease, orthodontic treatment that has been dis-
continued may be restarted [19]. Dental brushing should be rec-
ommended with fluoride toothpaste and 0.05% sodium fluoride 
rinse instead of  chlorhexidine rinses [8].
In the case of  bone marrow transplantation, after this procedure 
there is profound impairment of  the immune function, therefore, 
children may not undergo dental procedures up to 1 year, except 
non-invasive preventive treatment, such as fluoride topical appli-
cation, preventive resin restoration or fissure sealant etc. Results 
of  blood tests are required at all visits to the dentist. The hema-
tologist should be aware of  the possible long-term side effects 
of  chemo in the teeth, oral mucosa and craniofacial complex and 
should monitor the child for the same. Regular visits to the dentist 
should be encouraged [12].
The Performance of  the Dentist in the Care of  Children 
with Leukemia
According to Zimmermann et al., [19] modern oncology is de-
cisively a multiprofessional approach, based on the interaction 
between physicians, nurses, psychologists, physiotherapists, nutri-
tionists, pharmacists, speech therapists and dentists specialized in 
the field of  stomatology.
However, the generalist dentist can be present in the various 
phases of  the antineoplastic treatment, collaborating in the 
multiprofessional care of  the patient with leukemia, perform-
ing procedures such as adjustment of  the buccal environment, 
restorations, adjustments of  prostheses, endodontics. The dental 
care of  cancer patients has different phases, pre, trans and post 
chemotherapy or before, during and after anti-neoplastic therapy, 
remission of  the disease or case of  closed prognoses providing 
palliative care aiming at maintaining oral health, and quality of  
patients' lives [19].
As it is common for leukemia to present primarily oral alterations, 
such as gingival bleeding, petechiae, hematomas, bruises, ulcers, 
lymphadenopathy and gingival infection, causing the patient to 
seek dental treatment ends up making the dentist a fundamen-
tal part in the early diagnosis of  leukemias, identifying signs and 
symptoms such as increase of  infections, bleeding, neutropenic 
ulcers, and gingival and bone infiltration during routine dental 
care [19].
Rosso et al., [15] conducted a study with 23 patients, aged be-
tween 2 and 16 years, who had leukemia and found that 43.5% of  
the patients had caries, 30.4% hyperplasia, 21.7% mucositis and 
30.4% of  cases of  xerostomia becoming clear the necessity and 
the intervention of  the dentist to the improvement of  the oral 
health and the quality and life of  these patients.
The dentist should therefore be alert to these signs and have a 
duty to request a blood count to confirm or rule out the pos-
sibility that a leukemia may be the cause of  these changes. The 
patient may be surprised by the diagnosis of  leukemia during 
routine dental treatment, such as orthodontic treatment, and the 
general surgeon-dentist needs to know how to proceed in these 
situations [19].
Dental assessment presents different objectives according to 
the stage of  the pathology and the treatment. Before beginning 
cancer therapy when the patient is already diagnosed with leu-
kemia, he/she should receive a complete dental assessment, if  
possible, immediately after diagnosis and before chemotherapy, 
whose main objectives are: to identify specific leukemia diagnosis 
issues, such as leukemic infiltrate, identify and eliminate existing 
sources of  infection (carious lesions, extensive restorations and 
periodontal disease) or potential as local irritants. It should focus 
on oral hygiene care throughout the treatment (fluoride, brushing 
and non-cariogenic diet) without promoting complications or de-
laying cancer therapy; to educate the patient, parents or caregivers 
about the importance of  maintaining oral health, in order to re-
duce oral problems and discomforts before, during and after can-
cer treatment, and to alert about the possible effects of  therapy in 
the oral cavity [4, 19] .
The American Academy of  Pediatric Dentistry (2011) [1] also ad-
vocates dental sizing and preventive therapy, fluoride application 
and sealing of  fissures, removal of  non-restorable teeth, with per-
iodontal pockets larger than 6mm, with acute infection, bone loss 
furrow exposure, mobility, symptomatic impacted and residual 
roots, the extraction should ideally be performed two weeks be-
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fore the start of  antineoplastic treatment, or at least 7 to 10 days 
before. If  there was no dental treatment prior to antineoplastic 
therapy the decayed teeth should be filled with temporary fillings 
and the final treatment should be postponed until the patient is 
in remission [8].
According to Lowal et al., [8] in the case of  invasive procedures, 
the dentist should require a detailed dental examination with ra-
diographs; in case of  tooth extraction this should be done at least 
10-14 days before starting chemotherapy to allow adequate heal-
ing and to minimize the risk of  oral and systemic complications.
During antineoplastic therapy, the recommended dental care is 
three: to maintain excellent oral health; treat any adverse side ef-
fects of  antineoplastic therapy and reinforce to the patient the 
importance of  optimal oral health to reduce problems and dis-
comforts during chemotherapy treatment [19].
It is essential to minimize complications related to oral cavity dur-
ing antineoplastic treatment. With pre-evaluation of  oral health 
and appropriate dental management, possible oral sequelae can 
be prevented, reduced and relieved. Team approach is necessary 
to maximize results. The oncology team should clearly inform the 
dentist about the patient's health status and the cancer treatment 
plan [12].
In turn, dental staff  must communicate the oral health plan be-
fore, during and after cancer therapy. The dentist should obtain 
information about the type, stage and prognosis of  leukemia, cur-
rent treatment plan, most recent hematologic reports and their 
implications, from the oncology team. In addition, the dentist 
should also communicate with the oncology team about the state 
of  oral health, the possibilities of  its link to the existing condi-
tion, the proposed treatment plan and the time required to initiate 
treatment [12].
Conclusion
Immunosuppression and the very fragility and stage of  develop-
ment of  children with leukemia lead to greater vulnerability to all 
types of  opportunistic infections and pathologies resulting from 
antineoplastic therapy. Currently, modern oncology requires the 
presence of  the dentist in all phases of  treatment and even before 
diagnosis in a sine qua non condition for management, mainte-
nance of  oral health and quality of  life of  the leukemic patient. 
The dentist besides being part of  the cancer team is required both 
in the in-hospital environment and in daily clinical practice. Cur-
rently there is a wide range of  resources and medications to pro-
mote good management and quality and a satisfactory life, as was 
verified in this literature review.
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